Trial Profile
Phase III randomized trial comparing adjuvant chemotherapy with Fotemustine to surveillance in patients with a choroidal melanoma at high risk of relapse. [Etude de phase III randomisee comparant une chimiotherapie adjuvante par Fotemustine a une surveillance chez des patients presentant un melanome de la choroide a haut risque de rechute.]
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Jul 2020
Price :
$35
*
At a glance
- Drugs Fotemustine (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- Acronyms FOTE ADJ
- 05 Jul 2020 Status changed from recruiting to completed.
- 24 Aug 2011 New trial record